These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Coelingh K; Olajide IR; MacDonald P; Yogev R Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891 [TBL] [Abstract][Full Text] [Related]
25. Universal influenza vaccination and live attenuated influenza vaccination of children. Glezen WP Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568 [TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042 [TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Belshe RB; Ambrose CS; Yi T Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422 [TBL] [Abstract][Full Text] [Related]
28. Live attenuated influenza virus vaccine trial in children. Hall CB; Douglas G; Fralonardo SA Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767 [TBL] [Abstract][Full Text] [Related]
29. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036 [TBL] [Abstract][Full Text] [Related]
30. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Ambrose CS; Wu X; Jones T; Mallory RM Vaccine; 2012 Nov; 30(48):6794-801. PubMed ID: 23000125 [TBL] [Abstract][Full Text] [Related]
31. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children. Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; LondoƱo JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493 [TBL] [Abstract][Full Text] [Related]
32. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468 [TBL] [Abstract][Full Text] [Related]
34. Influenza vaccine 2008-2009. Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032 [TBL] [Abstract][Full Text] [Related]
35. Criteria in the evaluation of live intranasal influenza virus vaccines. Zygraich N Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962 [TBL] [Abstract][Full Text] [Related]
37. Emerging data on the safety and efficacy of influenza vaccines in children. Vesikari T Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892 [TBL] [Abstract][Full Text] [Related]
40. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults. Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]